BIMI (BIMI) Competitors

$1.10
+0.06 (+5.77%)
(As of 05/3/2024 ET)

BIMI vs. ZKIN, COSM, MEDS, KPRX, AYTU, PMD, PLAG, TTOO, ETAO, and MTEX

Should you be buying BIMI stock or one of its competitors? The main competitors of BIMI include ZK International Group (ZKIN), Cosmos Health (COSM), TRxADE HEALTH (MEDS), Kiora Pharmaceuticals (KPRX), Aytu BioPharma (AYTU), Psychemedics (PMD), Planet Green (PLAG), T2 Biosystems (TTOO), ETAO International (ETAO), and Mannatech (MTEX).

BIMI vs.

ZK International Group (NASDAQ:ZKIN) and BIMI (NASDAQ:BIMI) are both small-cap basic materials companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, community ranking, valuation, institutional ownership, dividends, media sentiment, profitability, earnings and risk.

ZK International Group has a beta of 2.05, meaning that its share price is 105% more volatile than the S&P 500. Comparatively, BIMI has a beta of 1.72, meaning that its share price is 72% more volatile than the S&P 500.

In the previous week, BIMI had 1 more articles in the media than ZK International Group. MarketBeat recorded 1 mentions for BIMI and 0 mentions for ZK International Group. BIMI's average media sentiment score of 0.00 beat ZK International Group's score of -0.33 indicating that ZK International Group is being referred to more favorably in the media.

Company Overall Sentiment
ZK International Group Neutral
BIMI Neutral

ZK International Group has a net margin of 0.00% compared to ZK International Group's net margin of -94.58%. BIMI's return on equity of 0.00% beat ZK International Group's return on equity.

Company Net Margins Return on Equity Return on Assets
ZK International GroupN/A N/A N/A
BIMI -94.58%-133.29%-33.85%

ZK International Group has higher revenue and earnings than BIMI.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ZK International Group$102.39M0.20-$6.08MN/AN/A
BIMI$11.83M1.08-$22.39MN/AN/A

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
ZK International Group
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
BIMI
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

ZK International Group received 179 more outperform votes than BIMI when rated by MarketBeat users. Likewise, 63.38% of users gave ZK International Group an outperform vote while only 57.50% of users gave BIMI an outperform vote.

CompanyUnderperformOutperform
ZK International GroupOutperform Votes
225
63.38%
Underperform Votes
130
36.62%
BIMIOutperform Votes
46
57.50%
Underperform Votes
34
42.50%

0.3% of ZK International Group shares are held by institutional investors. Comparatively, 0.1% of BIMI shares are held by institutional investors. 29.8% of ZK International Group shares are held by company insiders. Comparatively, 69.0% of BIMI shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Summary

ZK International Group beats BIMI on 10 of the 13 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BIMI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BIMI vs. The Competition

MetricBIMIDrugs, proprietaries, & sundries IndustryMedical SectorNASDAQ Exchange
Market Cap$12.75M$15.00B$4.99B$7.69B
Dividend YieldN/A1.29%2.87%3.97%
P/E RatioN/A36.26262.0918.73
Price / Sales1.081.942,428.5491.13
Price / CashN/A10.2048.5135.55
Price / Book0.818.414.864.37
Net Income-$22.39M$664.52M$103.80M$214.81M
7 Day Performance-10.57%0.53%3.89%2.25%
1 Month Performance-29.43%-7.37%-3.19%-2.18%
1 Year Performance18.85%2.92%5.72%11.32%

BIMI Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ZKIN
ZK International Group
0 of 5 stars
$0.66
+1.5%
N/A-14.2%$20.06M$102.39M0.00280Gap Down
COSM
Cosmos Health
1.298 of 5 stars
$0.53
+8.2%
N/A-78.8%$8.96M$50.35M0.00102Gap Up
MEDS
TRxADE HEALTH
0 of 5 stars
$6.50
-2.4%
N/A+14.3%$7.87M$11.45M-0.9433Gap Down
KPRX
Kiora Pharmaceuticals
1.693 of 5 stars
$0.58
+18.4%
$7.00
+1,107.9%
-83.1%$15.22MN/A0.0012
AYTU
Aytu BioPharma
1.1145 of 5 stars
$2.72
-3.2%
$5.00
+84.2%
+81.3%$15.12M$107.40M-0.67150Upcoming Earnings
PMD
Psychemedics
0 of 5 stars
$2.59
-2.3%
N/A-53.7%$15.05M$22.10M-3.60116Gap Down
PLAG
Planet Green
0 of 5 stars
$0.22
flat
N/A-64.5%$15.61M$27.12M-0.72143Gap Down
High Trading Volume
TTOO
T2 Biosystems
0.1853 of 5 stars
$2.72
-13.9%
N/A-87.7%$14.99M$7.19M0.00113Upcoming Earnings
News Coverage
ETAO
ETAO International
0 of 5 stars
$2.92
-3.0%
N/A-80.2%$14.96M$58.06M0.003,600News Coverage
MTEX
Mannatech
0.6673 of 5 stars
$8.33
flat
N/A-37.6%$15.67M$131.96M-6.94213Upcoming Earnings
Analyst Report
News Coverage

Related Companies and Tools

This page (NASDAQ:BIMI) was last updated on 5/4/2024 by MarketBeat.com Staff

From Our Partners